trazimera - trastuzumab - qyyp
(Trastuzumab-Qyyp)Pfizer Laboratories Div Pfizer Inc
Usage: Trazimera treats HER2-overexpressing breast cancer in adults, including adjuvant node-positive or high-risk node-negative disease, first-line metastatic breast cancer (with paclitaxel), and single-agent use after prior chemotherapy. Also indicated for HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma with cisplatin and capecitabine or 5-fluorouracil.